What is Multaq?

Multaq is a drug marketed by Sanofi Aventis. The drug is commonly prescribed to patients who suffer from atrial fibrillation. However, physicians also prescribe the drug to treat other medical conditions. However, the FDA has issued a warning that Multaq should only treat those with permanent atrial fibrillation, also known as heart fluttering on a short term basis, and physicians are required to monitor their patient’s heart rhythms at least every three months.

Multaq has been linked to serious side effects including causing severe liver damage.

The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.

Additional Multaq Articles

Search LawInfo's Multaq Resources

Related Topics In This Section